our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ET140203
i
Other names: ET140203, Autologous T cells transduced with lentivirus encoding an ET140203 expression construct, JWATM203, ET 140203, ET-140203, JWATM 203, JWATM-203
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
P1/2, N=6, Terminated, Eureka Therapeutics Inc. | N=12 --> 6 | Trial completion date: Jun 2026 --> Jun 2023 | Recruiting --> Terminated | Trial primary completion date: Apr 2024 --> Jun 2023; Directing efforts to the pediatric study (ARYA-2) for this product
7 months ago
Enrollment change • Trial completion date • Trial termination • Trial primary completion date • Metastases